ASCLF (Ascletis Pharma) FCF Margin %: -25,923.88% (As of Dec. 2025)

What is Ascletis Pharma FCF Margin %?

Ascletis Pharma ASCLF -4.00% 38 FCF Margin % is -25,923.88% as of Dec. 2025. GuruFocus rates ASCLF with a GF Score™ of 38/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 950 Biotechnology companies, Ascletis Pharma ranks worse than 95.16% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ascletis Pharma's Free Cash Flow for the six months ended in Dec. 2025 was $-34.74 Mil. Ascletis Pharma's Revenue for the six months ended in Dec. 2025 was $0.13 Mil. Therefore, Ascletis Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was -25,923.88%.

As of today, Ascletis Pharma's current FCF Yield % is -3.92%.

The historical rank and industry rank for Ascletis Pharma's FCF Margin % or its related term are showing as below:

ASCLF' s FCF Margin % Range Over the Past 10 Years
Min: -26787.37 Med: -377.43 Max: -59.14
Current: -20695.44

During the past 10 years, the highest FCF Margin % of Ascletis Pharma was -59.14%. The lowest was -26787.37%. And the median was -377.43%.

ASCLF's FCF Margin % is ranked worse than
95.16% of 950 companies
in the Biotechnology industry
Industry Median: -84.535 vs ASCLF: -20695.44

Ascletis Pharma FCF Margin % Related Terms

Ascletis Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Ascletis Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascletis Pharma FCF Margin % Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-200.48

-400.92

-429.30

-26,824.43

-20,643.75

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
FCF Margin %	Get a 7-Day Free Trial														-1,624.63	0.00	-10,845.45	-16,055.63	-25,923.88

ASCLF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Ascletis Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's FCF Margin % falls into.

Save Embed

38GF Score

Ascletis Pharma Inc ASCLF

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Ascletis Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ascletis Pharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-59.454	/	0.288
	=	-20,643.75 %

Ascletis Pharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-34.738	/	0.134
	=	-25,923.88 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -25,923.88% mean?

Ascletis Pharma (ASCLF) has a FCF Margin % of -25,923.88% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ascletis Pharma and its competitors. According to the industry distribution chart, Ascletis Pharma ranks #904 out of 950 companies in the Biotechnology industry, placing it in the top 95.2%.

Is Ascletis Pharma's FCF Margin % too high?

Ascletis Pharma's current FCF Margin % is -25,923.88%. Based on the distribution chart, Ascletis Pharma ranks #904 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ascletis Pharma has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Ascletis Pharma's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Ascletis Pharma ranks #904 out of 950 companies for FCF Margin %. This places Ascletis Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ascletis Pharma and its competitors. Ascletis Pharma's current FCF Margin % is -25,923.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ascletis Pharma stock overvalued right now?

Based on GuruFocus' analysis, Ascletis Pharma (ASCLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.44 — trading 7100% above its estimated fair value. The current FCF Margin % is -25,923.88%. Ascletis Pharma's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Ascletis Pharma (ASCLF), the current FCF Margin % is -25,923.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ascletis Pharma (ASCLF) Overvalued in 2026?

Based on GuruFocus' analysis, Ascletis Pharma stock appears to be overvalued. The current stock price of $1.44 is trading 7100% above its estimated GF Value™ of $0.02. GuruFocus considers Ascletis Pharma to be Significantly Overvalued.

Key valuation signals for ASCLF:

FCF Margin %: -25,923.88%
GF Value™: $0.02 vs. price of $1.44 (7100% above fair value)
GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the ASCLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ascletis Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies HKSE:02595 HKSE:09887 HKSE:02142 HKSE:01779 HKSE:01952 HKSE:02335 HKSE:02171 HKSE:06855 HKSE:06938 HKSE:02616 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 01672:Hong Kong 2VJ:Germany

Address No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, HKG, 311200

Website https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. The drug candidates of the company in the pipeline in their different stages of development such as ASC30, ASC47, ASC39, ASC36i, ASC35, ASC50, and among others.

38GF Score

Get the complete analysis for ASCLF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.44

Price

$0.02

GF Value

View ASCLF Analysis

See FCF Margin % data for all stocks →